But a new study from researchers at the University of Bristol offers fresh hope. It looks at how a well-known medicine called ...

The landmark Randomized Aldactone Evaluation Study (RALES), published in 1999, showed that spironolactone, a potassium-sparing diuretic, improves outcomes in patients with severe heart failure.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Spironolactone use among young women and girls has been growing since 2000 for acne and other androgen-related conditions.

investigated whether adding the aldosterone receptor antagonist spironolactone to renin–angiotensin system inhibition improved proteinuria in patients with diabetic nephropathy. Patients with ...